Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
about
Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancersThe cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporterTOX gene: a novel target for human cancer gene therapyG-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sampleTumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.TGF-β mediated DNA methylation in prostate cancer.DNA methylation gene-based models indicating independent poor outcome in prostate cancer.Wnt signalling in adenomas of familial adenomatous polyposis patients.RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.MethyQA: a pipeline for bisulfite-treated methylation sequencing quality assessment.Detection of bladder cancer using novel DNA methylation biomarkers in urine sedimentsExamination of whole blood DNA methylation as a potential risk marker for gastric cancer.Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.TOX acts an oncological role in mycosis fungoides.Methylome Analysis in Chickens Immunized with Infectious Laryngotracheitis VaccineComprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.Methylation status of NEUROG2 and NID2 improves the diagnosis of stage I NSCLC.Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma.Evaluation of logistic regression models and effect of covariates for case-control study in RNA-Seq analysis.Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.Identification of an epigenetic profile classifier that is associated with survival in head and neck cancer.Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast CancerSensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes.Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Global reactivation of epigenetically silenced genes in prostate cancer.In Silico Enhanced Restriction Enzyme Based Methylation Analysis of the Human Glioblastoma Genome Using Agilent 244K CpG Island Microarrays.Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis.Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer.DNA methylation in promoter region as biomarkers in prostate cancer.Cancer DNA methylation: molecular mechanisms and clinical implications.Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection?
P2860
Q21134689-54983DFE-2B17-4AC0-9602-7A23E7A0B770Q24338344-4AD1F7D3-EFCE-4307-8692-C6DA787CB918Q26765220-3887F5AA-C7B0-48BB-96F7-DC09DDF78004Q26801162-692077F1-227F-412C-904B-922376A706DCQ33383866-CF27959F-9EE7-48AB-A488-E4BB69C4BD27Q33579479-EFA476C7-71B9-4577-AA6B-06A4C75FEEFCQ33961765-2BF621BA-4D1A-4AE5-9696-31E35DD825D6Q34039935-71C360C8-59BE-4918-BE36-27B65D621CACQ34174356-574AE7FA-9D71-4B56-B4DE-0BAEB17823D0Q34253633-D9C93094-9AA3-4B06-8014-D95EEF472647Q34558896-F0A99B06-107A-4532-BBBD-910E2EB563E6Q34966469-17EC6403-D073-42A0-9B79-9D72BAF1F942Q35093755-D9E31B49-82BD-4D66-84D1-FE7E51039E0CQ35111866-98C9D148-CF99-424D-AD18-385C31ACD0FCQ35194198-8EC94ACE-5DEF-430E-A56D-EB1129129B8CQ35219716-AC6C288B-BD3C-46AB-ABC9-8C48492B080FQ35673328-667DCF34-813C-43FD-A101-8AA3B4CE64A9Q35751045-8FD02173-CFD2-4871-8C36-8883C7DDD10FQ35995443-C84F6ED4-36A3-4818-896E-724399371A4AQ36161868-4A7A3814-3306-44F4-9678-CD9D71C065D4Q36271926-8571C32D-ECCC-421B-A1B4-54C6A9D7022AQ36783894-466C1596-6BA8-411F-ACB9-E4B81B6FA03DQ36833387-3A0DAA4D-28AF-4DA2-8030-51D96174EC73Q37232922-EF45BE6F-E056-47DC-BEC9-74B07B0309A3Q37294995-6675CA2A-0810-42D1-85BE-012848A1987BQ37346216-3F59273B-9CE0-4F46-899D-76FF2353FDBBQ37463098-8A60B165-8FB0-4017-9FD5-AC3CFAD32711Q37690752-2D57F63E-A388-4AC6-A039-2767A0EDFA92Q38495819-E4BDEAB8-E585-4776-B3BC-B88B54CCA11EQ38500161-E10F20E0-1027-4D18-83F0-199E8C4A218CQ38894951-77761791-DBE3-450C-8DB0-66BB108D9AD9Q38983831-2D4C0C23-FC1B-40FC-A1AE-F0EA253D439CQ39079661-A677A40F-502F-4384-96D1-E991771D06A9Q39668899-CBE9117A-9E34-4A13-A0C3-2784F63BA1D5Q40156702-F185371E-44DF-4FE7-AE34-AA873B4742E4Q42141656-9B83D62D-99DB-4EB3-8B73-6CE0F23DE4F5Q42241147-05EDB513-8167-4293-BC1A-10CAE0B52DB7Q42261678-50757814-DC66-4461-AB6A-B1A5DB22F216Q42573635-1B87C4FC-4B5A-4B75-BD97-4AB69459720EQ43212184-4DE45384-611C-4E00-9777-BA092A46E46C
P2860
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Identification of novel tumor ...... nbiased methylation profiling.
@ast
Identification of novel tumor ...... nbiased methylation profiling.
@en
type
label
Identification of novel tumor ...... nbiased methylation profiling.
@ast
Identification of novel tumor ...... nbiased methylation profiling.
@en
prefLabel
Identification of novel tumor ...... nbiased methylation profiling.
@ast
Identification of novel tumor ...... nbiased methylation profiling.
@en
P2093
P2860
P1433
P1476
Identification of novel tumor ...... nbiased methylation profiling.
@en
P2093
Jaroslav Jelinek
Lanlan Shen
Michael Ittmann
Woonbok Chung
P2860
P356
10.1371/JOURNAL.PONE.0002079
P407
P577
2008-04-30T00:00:00Z